Atyr Pharma Inc (NASDAQ:ATYR) price on Thursday, February 27, remained unchanged to $3.87.
A look at the stock’s price movement, the close in the last trading session was $3.87. Turning to its 52-week performance, $4.66 and $1.42 were the 52-week high and 52-week low respectively. Overall, ATYR moved 11.85% over the past month.
Atyr Pharma Inc’s market cap currently stands at around $324.86 million, with investors looking forward to this quarter’s earnings report slated for in March.
Wall Street analysts have also projected the company’s year-on-year revenue to grow to 165.73k, representing a -53.05% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ATYR is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
ATYR’s current price about 0.62% and 6.07% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 51.90, while 7-day volatility ratio is 9.52% and 7.60% in the 30-day chart. Further, Atyr Pharma Inc (ATYR) has a beta value of 0.99, and an average true range (ATR) of 0.31.
If we refocus on Atyr Pharma Inc (NASDAQ:ATYR), historical trading data shows that trading volumes averaged 994.54K over the past 3 months. The company’s latest data on shares outstanding shows there are 83.94 million shares.
The 3.22% of Atyr Pharma Inc’s shares are in the hands of company insiders while institutional holders own 65.86% of the company’s shares. Current price change has pushed the stock 6.91% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ATYR stock continues to rise going into the next quarter.
